71 related articles for article (PubMed ID: 6627346)
1. Cell loss from viable and necrotic tumour regions measured by 125I-UdR.
Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Cell Tissue Kinet; 1983 Nov; 16(6):549-56. PubMed ID: 6627346
[TBL] [Abstract][Full Text] [Related]
2. Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Strahlenther Onkol; 1987 Nov; 163(11):723-8. PubMed ID: 3686335
[TBL] [Abstract][Full Text] [Related]
3. Cell loss from viable and necrotic tumor regions after local gamma irradiation measured by 125I-UdR.
Bornschein R; Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Strahlenther Onkol; 1987 Feb; 163(2):114-22. PubMed ID: 3563871
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival.
Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Radiat Environ Biophys; 1985; 24(3):219-26. PubMed ID: 4034927
[TBL] [Abstract][Full Text] [Related]
5. [DNA Turnover in the Whole Body of Tumour Bearing Mice (author's transl)].
Kronenberger PH; Porschen W; Feinendegen LE
Beitr Pathol; 1976 Dec; 159(4):398-412. PubMed ID: 1022223
[TBL] [Abstract][Full Text] [Related]
6. Retention of labelled 5-iodo-2-deoxyuridine after intratumorous injection as a possible indicator of the cellular kinetics.
Andrysek O; Bláhová E; Gregora V
Czech Med; 1984; 7(3):161-6. PubMed ID: 6499600
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
Bloomer WD; Adelstein SJ
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
[TBL] [Abstract][Full Text] [Related]
8. [3H]thymidine labels less than half of the DNA-synthesizing cells in the mouse tumour, carcinoma NT.
Hamilton E; Dobbin J
Cell Tissue Kinet; 1982 Jul; 15(4):405-11. PubMed ID: 7105131
[TBL] [Abstract][Full Text] [Related]
9. The use of 5-(125I)iodo-2'-deoxyuridine for monitoring DNA synthesis in organ culture.
Riches AC; Gore D; Docherty J; Littlewood V
J Anat; 1976 Apr; 121(Pt 2):323-9. PubMed ID: 58855
[TBL] [Abstract][Full Text] [Related]
10. The percentage labelled mitoses technique shows the mean cell cycle time to be half its true value in Carcinoma NT. II. [3H]deoxyuridine studies.
Hamilton E; Dobbin J
Cell Tissue Kinet; 1983 Sep; 16(5):483-92. PubMed ID: 6883432
[TBL] [Abstract][Full Text] [Related]
11. The effect of 125I-5-iodo-2'-deoxyuridine labelling on murine tumour cells.
Bishop CJ; Sheridan JW; Donald KJ
Br J Exp Pathol; 1981 Feb; 62(1):22-6. PubMed ID: 6784742
[TBL] [Abstract][Full Text] [Related]
12. Non-specific esterase activity in reactive cells in injured nervous tissue labeled with 3H-thymidine or 125iododeoxyuridine injected before injury.
Schelper RL; Adrian EK
J Comp Neurol; 1980 Dec; 194(4):829-44. PubMed ID: 7204643
[TBL] [Abstract][Full Text] [Related]
13. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
14. Cell loss from three established lines of the C3H mouse mammary tumor: a comparison of the 125I-UdR and the 3H-TdR-autoradiographic methods.
Dethlefsen LA; Sorenson J; Snively J
Cell Tissue Kinet; 1977 Sep; 10(5):447-59. PubMed ID: 922798
[TBL] [Abstract][Full Text] [Related]
15. [Transition of oxic cells to hypoxic cells in a murine squamous cell carcinoma].
Takai Y
Gan No Rinsho; 1989 Oct; 35(13):1543-7. PubMed ID: 2585725
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitivity of mouse seminal vesicle cells which show proliferative response to androgen and estrogen.
Okamoto S; Ogasawara Y; Kitamura Y; Matsumoto K; Mori KJ
Radiat Res; 1984 Jan; 97(1):132-8. PubMed ID: 6695038
[TBL] [Abstract][Full Text] [Related]
17. Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs.
Gauthier N; Lohm S; Touzery C; Chantôme A; Perette B; Reveneau S; Brunotte F; Juillerat-Jeanneret L; Jeannin JF
Carcinogenesis; 2004 Sep; 25(9):1559-65. PubMed ID: 15059928
[TBL] [Abstract][Full Text] [Related]
18. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
Vukanovic J; Isaacs JT
Cancer Res; 1995 Aug; 55(16):3517-20. PubMed ID: 7543015
[TBL] [Abstract][Full Text] [Related]
19. Proportion of necrosis in transplanted murine adenocarcinomas and its relationship to tumor growth.
Baker GM; Goddard HL; Clarke MB; Whimster WF
Growth Dev Aging; 1990; 54(3):85-93. PubMed ID: 2074122
[TBL] [Abstract][Full Text] [Related]
20. An assay for the measurement of residual damage of murine hematopoietic stem cells.
Häubner GE; Wangenheim KH; Feinendegen LE
Exp Hematol; 1981 Feb; 9(2):111-7. PubMed ID: 7016563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
